The efficacy and adverse effects of favipiravir on patients with COVID-19: A systematic review and meta-analysis of published clinical trials and observational studies-Reference-Cited by-同舟云学术

The efficacy and adverse effects of favipiravir on patients with COVID-19: A systematic review and meta-analysis of published clinical trials and observational studies

Published:2022-07 Issue: Volume:120 Page:217-227
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Hung Dang The,Ghula Suhaib,Aziz Jeza Muhamad Abdul^ORCID,Makram Abdelrahman M.^ORCID,Tawfik Gehad Mohamed,Abozaid Ali Ahmed-Fouad,Pancharatnam Rohan Andrew,Ibrahim Amr Mohamed,Shabouk Muhammad Besher^ORCID,Turnage Morgan^ORCID,Nakhare Saloni^ORCID,Karmally Zahra,Kouz Basel^ORCID,Le Tran Nhat,Alhijazeen Suleiman,Phuong Nguyen Quoc,Ads Alaa Mohamed,Abdelaal Ali Hussein^ORCID,Nam Nguyen Hai^ORCID,Iiyama Tatsuo^ORCID,Kita Kyoshi,Hirayama Kenji,Huy Nguyen Tien^ORCID

Funder

University of Buckingham

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference85 articles.

1. Favipiravir: a new and emerging antiviral option in COVID-19;Agrawal;Med J Armed Forces India,2020

2. Aleem A, Remdesivir KJ. StatPearls [internet]; 2021. StatPearls (updated 2021 Jan 10).

3. Remdesivir and favipiravir changes hepato-renal profile in COVID-19 patients: a cross sectional observation in;Ara Perveen;Bangladesh. ijmsci,2021

4. Fluorescence of nails and hair on Wood's lamp examination in Covid Pandemic; undefined effect of favipiravir in humans;Aslan Kayıran;Dermatol Ther,2021

5. Traveling for heart transplantation and returning with COVID-19: a logistical, clinical, and pharmacotherapeutic challenge from the Middle East;Atallah;Drugs Ther Perspect,2020

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the therapeutic potential of edible mushrooms: Ganoderma and their secondary metabolites as novel antiviral agents for combating COVID-19;New Zealand Journal of Botany;2024-08-08

2. Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action;Heliyon;2024-08

3. Favipiravir‐induced bradycardia: A case report;Clinical Case Reports;2024-06-27

4. Favipiravir does not improve viral clearance in mild to moderate COVID-19 – A systematic review and meta-analysis of randomized controlled trials;Heliyon;2024-05

5. Pharmacogenomic Studies of Antiviral Drug Favipiravir;Pharmaceutics;2024-04-07